/Investor DB

Cathay Health

Venture capital

San Francisco · Seed–Late Stage · 3 people tracked

Also known as CATHAY CAPITAL NA, LLC

Find your way into Cathay Health

Sign up to see every warm intro you have to Cathay Health

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Cathay Health team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

✨ Fox Verdict
Sign up to see your fit

Investment thesis

Cathay Health invests in companies operating at the convergence of life sciences, healthcare, and technology, targeting positive impact on human health. Its focus areas include life science tools, diagnostics, clinical trial innovation, new care models, novel devices and materials, and enabling technologies for advanced therapies. The firm both invests in and operates at this convergence, backing businesses spanning surgical robotics, biomaterials, gene and cell therapy manufacturing, and health tech venture creation.

Source: firm website, verified Sep 29, 2026.

Stage
Seed–Late Stage
HQ
San Francisco, NY, US
Instruments
Equity
Founded
2021
AUM
$76.6M
Tracked investments
6

Team · 3 people

from public directories
Wenwen He· Vice Presidentin

What they invest in

from 4 of 6 portfolio companies

Biotech ×3Medical Devices ×3Healthtech ×2Deep Tech ×1New Materials ×1Robotics ×1

HQs:United States×2Germany×1France×1

Investments · 6 tracked

founders shown can be your intro path

By year:2024 · 12023 · 12021 · 13 dated

Ascend Advanced Therapiesascend-adv.cominNov 2024

Ascend is a gene-to-GMP development partner that helps life-science companies advance advanced therapy products from the research bench through clinical stages.

BiotechHealthtechMedical DevicesMunich, DE

Evis Hursever(Executive Officer)Wesley McConnell(Executive Officer)inMichael Stella(Executive Officer, Director)William Hawkins(Executive Officer)

BoardMichael Beecham(Director)Andrew Kozlov(Director)

PartnerEric De La Fortelle· solo GP

Co-investorsDCVC (Data Collective)Monograph Capital Partners4BIO CapitalDigitalis Ventures

Ganymed Roboticsganymedrobotics.com

Sophie Cahen(Founder)in

PartnerEric De La Fortelle· solo GP

Co-investorsKurma PartnersCAP HORN VC

Initiate Studioinitiate.studio

PartnerEric De La Fortelle· solo GP

Kojin TherapeuticsinJun 2021

BiotechBoston, US

Nagesh Mahanthappa, Ph.D.(Director)Luba Greenwood(Director)in

BoardAmir Nashat, Ph.D.(Treasurer and Secretary)Susan Langer(President)Thomas J. Cahill(Director)

Co-investors5AM VenturesNewpath PartnersPolaris Partners

Moon Surgicalmoonsurgical.comin𝕏May 2023 · $55M

Moon Surgical develops the Maestro robotic surgery system, a digital surgical robotics platform used by surgeons to perform procedures.

HealthtechMedical DevicesRoboticsParis, FR

Brice Gayet(Founder)inAnne Osdoit(Chief Executive Officer)inEric Ermenault(Chief Commercial Officer)inAnne Renevot(Chief Financial Officer)inViola Fleig(Chief Operations Officer)inDavid Noonan(Chief Technology Officer)in

PartnerEric De La Fortelle· solo GP

Co-investorsNVIDIASofinnova PartnersStar51 CapitalJohnson & Johnson Innovation – JJDCNVentures

Tissiumtissium.com𝕏

TISSIUM develops biomorphic polymer technology, including proprietary polymers, activation technologies, and delivery devices, to reconstruct damaged tissue and restore its function across multiple therapeutic areas.

BiotechDeep TechMedical DevicesNew Materials

Christophe Bancel(Co-founder & CEO)inMaria Pereira(Co-inventor of the technology; leads the Innovation Hub)in

PartnerEric De La Fortelle· solo GP

Co-investorsCapDecisif ManagementKaristaSofinnova PartnersCathay InnovationEuropean Investment BankOmnes Capital

Portfolio news

latest coverage across their companies

Frequently asked questions

How many investments has Cathay Health made?
Cathay Health has 6 tracked investments, including 1 dated in the last 24 months.
What stage does Cathay Health invest at?
Cathay Health invests at the Seed, Series A, Series B, Series C, Growth, Late Stage stages.
What sectors does Cathay Health focus on?
Cathay Health focuses on Advanced Manufacturing, Biotech, Consumer, Crypto & Web3, Deep Tech, Digital Health, Healthtech, Medical Devices, New Materials, Robotics.
Where is Cathay Health located?
Cathay Health is headquartered in San Francisco, US.
Who does Cathay Health co-invest with?
Cathay Health most often shares deals with Sofinnova Partners, DCVC (Data Collective), Kurma Partners, among 8 tracked co-investors.

Images

Cathay Health photoCathay Health photo

Similar investors

Featured in lists